leadf
logo-loader
AIM:REDX FRA:0RX

Redx Pharma PLC

 Receive alerts
Market:
AIM
Market Cap:
£171.18 m
Price
62.50 GBX
Change
0.00%
52 weeks high
94.95
52 weeks low
4.50
05.46

Director Interviews

In brief

Redx is a biotech company focused on the discovery and development of novel targeted medicines for the treatment of cancer and fibrotic disease, aiming to progress them to clinical proof of concept (PoC).

In brief Deep dive Research Latest news Insight Interviews

Deep dive We explore the investor case for growth companies

Redx Pharma upbeat as funding rounds underline potential
researcher at microscope

Snapshot

  • Cancer drug in the clinic 
  • Promising fibrosis treatments targeting large markets
  • Deals with AstraZeneca and Jazz Pharmaceuticals
Open Deep dive

Latest news

Proactive news headlines: Clipper Logistics, Digitalbox, Incanthera, ReNeuron...

1 week, 2 days ago

Redx Pharma says it has the ability to deliver "multiple inflexion points"...

on 27/1/21

Redx Pharma says it has conditionally raised around £25.5mln before expenses...

on 2/12/20

Redx Pharma to welcome new chief medical officer in March 2021

on 27/10/20

Redx Pharma unveils second major collaboration in a month as it strengthens...

on 9/9/20

Redx Pharma rockets as it licenses out novel IPF drug to AstraZeneca

on 4/8/20

Redx Pharma to raise US$30mln to advance drug pipeline

on 30/6/20

Redx Pharma’s majority shareholder Redmile ups stake to 91.76% of the company

on 1/5/20

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Redx Pharma PLC - Redx Pharma strikes balance between in-house programmes and partnerships Redx Pharma strikes balance between in-house programmes and partnerships
on 12/9/20
Feature

Are small-cap biotech stocks good investments now?

on 15/8/20
Insight

Redx Pharma: the three-year journey from administration to FTSE 100 deal

on 14/8/20
Feature

Redx Pharma hopes Astra deal will shine light on fibrosis treatments

on 5/8/20

Watch

Redx Pharma PLC - Small caps Redx Pharma mark 'transformational year for the company with significant pipeline'
on 28/1/21
Redx Pharma PLC - Redx Pharma £25.5m raise 'to drive forward our two key programmes, at pace' Director Interviews Redx Pharma £25.5m raise 'to drive forward our two key programmes, at pace'
on 7/12/20
Redx Pharma PLC - Small caps RedX Pharma presents at the Proactive One2One Virtual Conference
on 31/10/20
Redx Pharma PLC - Redx Pharma PLC in a great place to move forward after Astra deal says CEO Director Interviews Redx Pharma PLC in a great place to move forward after Astra deal says CEO
on 5/8/20
View all